JTCR016: Phase I/II data

Top-line data from 3 patients with WT1-expressing stage III or IV NSCLC or mesothelioma in an open-label, dose-escalation, U.S. Phase I/II

Read the full 219 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE